XLRN

Acceleron Pharma Inc

No insider bought or sold Acceleron Pharma Inc in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow XLRN

XLRN over the last year

Prices for XLRN aren't in yet.

XLRN after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

96 insider filings since 2016, newest first

XLRNSell

Sujay Kango · EVP and Chief Commercial Officer

$875K−21.0%Sep 27

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$4.0M−70.0%Sep 24

XLRNSell

Adam M Veness · SVP, GC, Sec.

$998K−26.0%Sep 22

XLRNSell

Sujay Kango · EVP and Chief Commercial Officer

$750K−21.0%Sep 22

XLRNSell

Adam M Veness · SVP, GC, Sec.

$184K−7.0%Sep 9

XLRNSell

Habib J Dable · CEO and President

$12.7M−50.0%Jul 2

XLRNSell

Thomas A Mccourt · Director

$894K−55.0%Apr 21

XLRNSell

Joseph S Zakrzewski · Director

$1.4M−22.0%Apr 5

XLRNSell

Karen L. Smith · Director

$1.7M−88.0%Apr 5

XLRNSell

Joseph S Zakrzewski · Director

$1.3M−22.0%Apr 2

XLRNSell

Karen L. Smith · Director

$1.2M−66.0%Apr 2

XLRNSell

Sujay Kango · EVP and Chief Commercial Officer

$680K−20.0%Mar 4

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$589K−45.0%Jan 6

XLRNSell

Habib J Dable · CEO and President

$516K−5.0%Jan 6

XLRNSell

Adam M Veness · SVP, GC, Sec.

$252K−11.0%Jan 6

XLRNSell

Sujay Kango · EVP and Chief Commercial Officer

$1.3M−71.0%Jan 6

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$5.5M−79.0%Dec 15

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$934K−40.0%Dec 11

XLRNSell

Terrence C Kearney · Director

$4.5M−88.0%Oct 13

XLRNSell

Thomas A Mccourt · Director

$2.1M−84.0%Sep 15

XLRNSell

Adam M Veness · SVP, GC, Sec.

$179K−9.0%Sep 9

XLRNSell

Celgene Corp /de/ · 10% owner

$229KJul 13

XLRNSell

Habib J Dable · CEO and President

$4.8M−36.0%Jul 6

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$4.7M−83.0%Apr 10

XLRNSell

Adam M Veness · SVP, GC, Sec.

$514K−22.0%Apr 10

XLRNSell

Sujay Kango · EVP and Chief Commercial Officer

$56K−4.0%Feb 14

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$293K−54.0%Jan 3

XLRNSell

Habib J Dable · CEO and President

$191K−5.0%Jan 3

XLRNSell

Adam M Veness · VP, GC, Sec.

$68K−8.0%Jan 3

XLRNSell

John D Quisel · EVP and Chief Business Officer

$307K−10.0%Jan 3

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$596K−53.0%Dec 17

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$362K−26.0%Sep 10

XLRNSell

Habib J Dable · CEO and President

$254K−7.0%Sep 10

XLRNSell

Adam M Veness · VP, GC, Sec.

$37K−5.0%Sep 10

XLRNSell

Ravindra Kumar · SVP and Chief Scientific Officer

$153K−4.0%Sep 10

XLRNSell

John D Quisel · EVP and Chief Business Officer

$162K−6.0%Sep 10

XLRNSell

Adam M Veness · VP, GC, Sec.

$147K−16.0%Aug 12

XLRNSell

Jean George · Director

$1.5M−91.0%Jun 28

XLRNBuy

Joseph S Zakrzewski · Director

$190K+65.0%Jun 17

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$535K−28.0%Apr 11

XLRNSell

Habib J Dable · CEO and President

$333K−9.0%Apr 11

XLRNSell

Ravindra Kumar · SVP and Chief Scientific Officer

$162K−4.0%Apr 11

XLRNSell

John D Quisel · EVP, CBO, Secretary

$162K−6.0%Apr 11

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$31K−2.0%Apr 4

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$244K−13.0%Jan 4

XLRNSell

Habib J Dable · CEO and President

$85K−3.0%Jan 4

XLRNSell

Ravindra Kumar · SVP and Chief Scientific Officer

$249K−6.0%Jan 4

XLRNSell

John D Quisel · EVP, CBO, Secretary

$254K−10.0%Jan 4

XLRNSell

Habib J Dable · CEO and President

$672K−16.0%Dec 6

XLRNSell

Kevin F Mclaughlin · SVP, CFO and Treasurer

$675K−22.0%Aug 31

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.